The 2019 BridgeTech Program has officially been launched at QUT’s Institute of Health and Biomedical Innovation in Brisbane.
The launch brought together the successful 2019 program participants in addition to representatives from industry, universities, industry associations, government, medtech researchers, entrepreneurs and 2018 Program alumni.
Administered by QUT, The BridgeTech Program is jointly funded by the Medical Technologies and Pharmaceuticals Growth Centre (MTPConnect) and a consortium of medical technology companies, universities and industry associations.
The program is designed to support and enhance the commercialisation of Australian medical technology and medical devices via the professional development and training of researchers and entrepreneurs.
Participants in the program are selected from a competitive pool of applicants. They receive commercialisation training and advice through a 12-month program including online training modules, a rotating series of seminars and a three-day intensive training symposium.
Participants are also introduced to a growing network of program alumni and have access to advice and expertise from the industry consortium whose representatives include Stryker, Siemens Healthcare and Cochlear.
Following the success of the BridgeTech Program and its sister program – The Bridge Program – both programs recently received multi-year funding commitments through MTPConnect and the federal government’s Medical Research Future Fund.